Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Effect of Exercise on Pharmacokinetics

Ylitalo, Pauli · 1991 · Annals of Medicine

Abstract

The increasing popularity of sporting events, even for people on drug treatment, has raised the question of the interaction of exercise and pharmacokinetics. Exercise reduces splanchnic blood flow, but possible changes in the absorption of orally given drugs seem to be of minor clinical significance. Absorption from intramuscular, subcutaneou and transdermal application sites may be accelerated by exercise, possibly causing harmful consequences, e.g. in diabetics treated with insulin. Exercise or physical work increases the rate and depth of respiration thus increasing alveolar exchange of gases and vapours. Physical activity increases muscular blood flow and the binding of digoxin to muscular structures, with a simultaneous fall in the concentration of serum digoxin. Reduction in blood flow to adipose and other inactive tissues may delay the distribution of some drugs that are stored or removed by these tissues. The change from supine to upright position can affect the distribution of a drug. Exercise reduces the blood flow in the liver and deactivation of drugs with flow-limited (high clearance) hepatic metabolism such as nitrates and lidocaine. Metabolism of capacity-limited (low clearance) drugs, e.g. antipyrine, diazepam and amobarbital, is not influenced by exercise. Renal plasma flow, urine excretion rate and urine pH are also reduced by exercise. This is an important reason why the serum levels of drugs eliminated through the kidneys increase during physical stress. The changes in parenteral absorption and distribution volume of some drugs caused by exercise, as well as the short half-life of drugs, are properties resulting in altered therapeutic/toxic response in those drugs with a narrow therapeutic range.

Overview

Integrity signals

Registry

Crossref · 10.3109/07853899109148062

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 10

  1. Selkurt E E, 1963, Handbook of physiology, 2, 1457
  2. Schwartz R D., 1974, J Pharmacol Exp Ther, 188, 1
  3. Ylitalo P, 1985, Int J Clin Pharmacol Ther Toxicol, 23, 548
  4. Laursen SØ, 1987, Dan Med Bull, 34, 115
  5. Hurwitz G A., 1979, Circulation, 59, 11
  6. Marsh T D., 1983, Clin Pharm, 2, 62
  7. Gamble J AS, 1975, Proc R Soc Med, 68, 772
  8. Menzel D B., 1986, Casarett and Doull's toxicology. 3rd ed, 330
  9. Dettli L, 1966, Helv Med Acta, 33, 291
  10. Jogestrand T, 1981, Acta Med Scand, 38

Cited by

See all 41

Metadata

Authors
Ylitalo, P.
Affiliations
University of Eastern Finland (FI)
Corresponding author
Ylitalo, Pauli
Venue
Annals of Medicine
Published
1991-01
Volume
23
Issue
3
Pages
289-294
ISSN
  • 0785-3890 (ISSN-L)
  • 1365-2060
OpenAlex
W2021999445
Cited by
38
References
41
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2022: 3 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 1
FWCI
0.10
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
Keywords
physical activity, pharmacokinetics, drug absorption, drug distribution, drug metabolism, renal excretion, insulin, digoxin, hepatic blood flow, renal plasma flow, drug interactions, drug elimination, narrow therapeutic index drugs
MeSH terms
Humans, Pharmacokinetics, Exercise

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Exercise on Pharmacokinetics. https://app.cochat.ai/papers/10.3109/07853899109148062
The paper
Ylitalo, P. (1991). Effect of Exercise on Pharmacokinetics. Annals of Medicine. https://doi.org/10.3109/07853899109148062

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.